PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-IIb

Jazz Pharmaceuticals’ Zanidatamab Secures the CHMP Positive Opinion to Treat HER2+ Biliary Tract Cancer (BTC)

Jazz Pharmaceuticals’ Zanidatamab Secures the CHMP Positive Opinion to Treat HER2+ Biliary Tract Cancer (BTC)

April 28, 2025

Johnson & Johnson’s Tremfya Receives the EC’s Approval for Active Ulcerative Colitis (UC)

Johnson & Johnson’s Tremfya Receives the EC’s Approval for Active Ulcerative Colitis (UC)

April 25, 2025

Eccogene Reports the First Patient Dosing with ECC5004/AZD5004 in P-IIb Trial of Obesity and T2D, Triggering $60M Milestone from AstraZeneca

Eccogene Reports the First Patient Dosing with ECC5004/AZD5004 in P-IIb Trial of Obesity and T2D, Triggering $60M Milestone from A...

October 23, 2024

GSK Reports the CHMP’s Positive Opinion of Menveo Vaccine Against Invasive Meningococcal Disease

GSK Reports the CHMP’s Positive Opinion of Menveo Vaccine Against Invasive Meningococcal Disease

September 24, 2024

Immutep Provides Data from the P-IIb (TACTI-003) Study of Eftilagimod Alfa to Treat Head and Neck Squamous Cell Carcinoma

Immutep Provides Data from the P-IIb (TACTI-003) Study of Eftilagimod Alfa to Treat Head and Neck Squamous Cell Carcinoma

July 12, 2024

Zymeworks Reports the NMPA’s BLA Acceptance of Zanidatamab to Treat Biliary Tract Cancer

Zymeworks Reports the NMPA’s BLA Acceptance of Zanidatamab to Treat Biliary Tract Cancer

June 10, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us